BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chevigné A, Fievez V, Szpakowska M, Fischer A, Counson M, Plesséria JM, Schmit JC, Deroo S. Neutralising properties of peptides derived from CXCR4 extracellular loops towards CXCL12 binding and HIV-1 infection. Biochim Biophys Acta 2014;1843:1031-41. [PMID: 24480462 DOI: 10.1016/j.bbamcr.2014.01.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Santagata S, Ieranò C, Trotta AM, Capiluongo A, Auletta F, Guardascione G, Scala S. CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment. Front Oncol 2021;11:591386. [PMID: 33937018 DOI: 10.3389/fonc.2021.591386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chevigné A, Janji B, Meyrath M, Reynders N, D'Uonnolo G, Uchański T, Xiao M, Berchem G, Ollert M, Kwon YJ, Noman MZ, Szpakowska M. CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6. Cancers (Basel) 2021;13:1054. [PMID: 33801414 DOI: 10.3390/cancers13051054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
3 Liang GQ, Liu J, Zhou XX, Lin ZX, Chen T, Chen G, Wei H. Anti-CXCR4 Single-Chain Variable Fragment Antibodies Have Anti-Tumor Activity. Front Oncol 2020;10:571194. [PMID: 33392074 DOI: 10.3389/fonc.2020.571194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Adlere I, Caspar B, Arimont M, Dekkers S, Visser K, Stuijt J, de Graaf C, Stocks M, Kellam B, Briddon S, Wijtmans M, de Esch I, Hill S, Leurs R. Modulators of CXCR4 and CXCR7/ACKR3 Function. Mol Pharmacol 2019;96:737-52. [DOI: 10.1124/mol.119.117663] [Cited by in Crossref: 21] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
5 Koksal AC, Pennini ME, Marelli M, Xiao X, Dall'Acqua WF. Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffold. MAbs 2019;11:725-34. [PMID: 30900513 DOI: 10.1080/19420862.2019.1596703] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Willems E, Dedobbeleer M, Digregorio M, Lombard A, Goffart N, Lumapat PN, Lambert J, Van den Ackerveken P, Szpakowska M, Chevigné A, Scholtes F, Rogister B. Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration. Oncogene 2019;38:73-87. [PMID: 30082913 DOI: 10.1038/s41388-018-0437-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
7 Szpakowska M, Meyrath M, Reynders N, Counson M, Hanson J, Steyaert J, Chevigné A. Mutational analysis of the extracellular disulphide bridges of the atypical chemokine receptor ACKR3/CXCR7 uncovers multiple binding and activation modes for its chemokine and endogenous non-chemokine agonists. Biochemical Pharmacology 2018;153:299-309. [DOI: 10.1016/j.bcp.2018.03.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
8 Szpakowska M, Nevins AM, Meyrath M, Rhainds D, D'huys T, Guité-Vinet F, Dupuis N, Gauthier PA, Counson M, Kleist A, St-Onge G, Hanson J, Schols D, Volkman BF, Heveker N, Chevigné A. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3. Br J Pharmacol 2018;175:1419-38. [PMID: 29272550 DOI: 10.1111/bph.14132] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 6.5] [Reference Citation Analysis]
9 Fievez V, Szpakowska M, Mosbah A, Arumugam K, Mathu J, Counson M, Beaupain N, Seguin-Devaux C, Deroo S, Baudy-Floc'h M, Chevigné A. Development of Mimokines, chemokine N terminus-based CXCR4 inhibitors optimized by phage display and rational design. J Leukoc Biol 2018;104:343-57. [PMID: 29570832 DOI: 10.1002/JLB.3MA0118-007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
10 Dupuis N, Laschet C, Franssen D, Szpakowska M, Gilissen J, Geubelle P, Soni A, Parent AS, Pirotte B, Chevigné A, Twizere JC, Hanson J. Activation of the Orphan G Protein-Coupled Receptor GPR27 by Surrogate Ligands Promotes β-Arrestin 2 Recruitment. Mol Pharmacol 2017;91:595-608. [PMID: 28314853 DOI: 10.1124/mol.116.107714] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
11 Chevigne A, Delhalle S, Counson M, Beaupain N, Rybicki A, Verschueren C, Staub T, Schmit J, Seguin-devaux C, Deroo S. Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller: . AIDS 2016;30:377-82. [DOI: 10.1097/qad.0000000000000925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kleist AB, Getschman AE, Ziarek JJ, Nevins AM, Gauthier PA, Chevigné A, Szpakowska M, Volkman BF. New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. Biochem Pharmacol 2016;114:53-68. [PMID: 27106080 DOI: 10.1016/j.bcp.2016.04.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 10.8] [Reference Citation Analysis]
13 Pawig L, Klasen C, Weber C, Bernhagen J, Noels H. Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives. Front Immunol 2015;6:429. [PMID: 26347749 DOI: 10.3389/fimmu.2015.00429] [Cited by in Crossref: 99] [Cited by in F6Publishing: 109] [Article Influence: 14.1] [Reference Citation Analysis]
14 Abayev M, Moseri A, Tchaicheeyan O, Kessler N, Arshava B, Naider F, Scherf T, Anglister J. An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions. FEBS J 2015;282:1906-21. [PMID: 25703038 DOI: 10.1111/febs.13243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
15 Groß A, Brox R, Damm D, Tschammer N, Schmidt B, Eichler J. Ligand selectivity of a synthetic CXCR4 mimetic peptide. Bioorg Med Chem 2015;23:4050-5. [PMID: 25801155 DOI: 10.1016/j.bmc.2015.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]